These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 350042)

  • 1. Evaluation of compounding accuracy and aseptic techniques for intravenous admixtures.
    Sanders LH; Mabadeje SA; Avis KE; Cruze CA; Martinez DR
    Am J Hosp Pharm; 1978 May; 35(5):531-6. PubMed ID: 350042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating aseptic technique of pharmacy personnel.
    Brier KL
    Am J Hosp Pharm; 1983 Mar; 40(3):400-3. PubMed ID: 6342376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Qaulity-control plan for intravenous admixture programs. II: Validation of operator technique.
    Morris BG; Avis KE; Bowles GC
    Am J Hosp Pharm; 1980 May; 37(5):668-72. PubMed ID: 7386475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. I.V. admixture contamination rates: traditional practice site versus a class 1000 cleanroom.
    Thomas M; Sanborn MD; Couldry R
    Am J Health Syst Pharm; 2005 Nov; 62(22):2386-92. PubMed ID: 16278330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Method for testing aseptic technique of intravenous admixture personnel.
    Dirks I; Smith FM; Furtado D; White SJ; Godwin HN
    Am J Hosp Pharm; 1982 Mar; 39(3):457-9. PubMed ID: 7041641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compounding times and contamination rates associated with the preparation of intravenous admixtures in three types of plastic containers.
    Allinson RR; Stach PE; Sherrin TP; Latiolais CJ
    Am J Hosp Pharm; 1979 Apr; 36(4):513-7. PubMed ID: 433938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of two sterility testing methods for intravenous admixtures.
    Condella F; Eichelberger K; Foote LC; Griffin RE
    Hosp Pharm; 1980 Jun; 15(6):305-10. PubMed ID: 10247270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of two work practice changes on the microbial contamination rates of pharmacy-compounded sterile preparations.
    Trissel LA; Gentempo JA; Saenz LM; Woodard MY; Angeles CH
    Am J Health Syst Pharm; 2007 Apr; 64(8):837-41. PubMed ID: 17420200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A first-phase quality assurance program for intravenous admixture aseptic technique.
    Gurwich EL; Hanold L; Schaeffer P
    Hosp Pharm; 1982 Mar; 17(3):119-21. PubMed ID: 10255637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Premixed intravenous admixtures: a positive development for hospital pharmacy.
    Lee HE
    Am J Hosp Pharm; 1983 Jun; 40(6):1043-4. PubMed ID: 6869393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basics of Sterile Compounding: Personnel Requirements for Sterile Compounding.
    Akers MJ
    Int J Pharm Compd; 2016; 20(4):307-314. PubMed ID: 28333676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Personnel time and preparation costs for compounded versus premixed intravenous admixtures in three community hospitals.
    Kirschenbaum BE; Cacace L; Anderson RJ; Ackerman LA
    Am J Hosp Pharm; 1988 Mar; 45(3):605-8. PubMed ID: 3369464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recommended methods for compounding intravenous admixtures in hospitals.
    Am J Hosp Pharm; 1975 Mar; 32(3):261-70. PubMed ID: 1136973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using a medium-fill simulation to evaluate the microbial contamination rate for USP medium-risk-level compounding.
    Trissel LA; Gentempo JA; Anderson RW; Lajeunesse JD
    Am J Health Syst Pharm; 2005 Feb; 62(3):285-8. PubMed ID: 15719586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of laminar air flow and clean-room dress on contamination rates of intravenous admixtures.
    Brier KL; Latiolais CJ; Schneider PJ; Moore TD; Buesching WJ; Wentworth BC
    Am J Hosp Pharm; 1981 Aug; 38(8):1144-7. PubMed ID: 7270557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of the aseptic processing environment.
    Frieben WR
    Am J Hosp Pharm; 1983 Nov; 40(11):1928-35. PubMed ID: 6650522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sterility-testing program for antibiotics and other intravenous admixtures.
    Choy FN; Lamy PP; Burkhart VD; Tenney JH
    Am J Hosp Pharm; 1982 Mar; 39(3):452-6. PubMed ID: 7041640
    [No Abstract]   [Full Text] [Related]  

  • 18. Time-motion study of intravenous ranitidine admixtures.
    Gonzalez ER; Hruska BM; Elswick RK; Wood CF; Pesko LJ
    DICP; 1990 Jun; 24(6):590-2. PubMed ID: 2360336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Premixed intravenous admixtures: a critical challenge for hospital pharmacy.
    Loeb AJ; Fishman DA; Kochis TR
    Am J Hosp Pharm; 1983 Jun; 40(6):1041-3. PubMed ID: 6869392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized trial comparing pharmacists and technicians as dispensers of prescriptions for ambulatory patients.
    McGhan WF; Smith WE; Adams DW
    Med Care; 1983 Apr; 21(4):445-53. PubMed ID: 6843197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.